Access Denied

You don’t have permission to access “http://www.globenewswire.com/news-release/2026/10/16/3382249/0/en/fda-approves-roche-s-enspryng-a-first-in-class-il-6r-inhibitor-as-the-first-and-only-at-home-subcutaneous-treatment-option-for-thyroid-eye-disease-ted.html” on this server.

Reference #18.8dc44d17.1792127954.2d5e0f5

https://errors.edgesuite.net/18.8dc44d17.1792127954.2d5e0f5